Stage Iiib Lung Cancer Ajcc V8

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2023-06-01
Clinical Trial Update: EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer [Phase 1, Phase 2]
Clinical trial update for EMB-01 in combination with Osimertinib in EGFR-mutant lung cancer, spanning Phase 1 and Phase 2.